Navigating Changes in Compounded Semaglutide and Tirzepatide: How Candescent Health & Wellness is Keeping You Protected
Breaking Down the FDA’s GLP-1 Ruling with WNDU 16 News Now
Candescent Health and Wellness spoke with WNDU 16 News Now about the recent FDA ruling that will discontinue compounded versions of popular weight-loss medications.
With one in eight adults in Indiana using these medications, we understand many may have questions.
At Candescent Health & Wellness, our top priority has always been the well-being of our patients. As changes loom for compounded Semaglutide and Tirzepatide, we remain committed to ensuring that you continue to receive the highest quality care and support during this transition.
Recently, we had the opportunity to sit down with @lomossy and the team at @16newsnow to discuss these upcoming changes and what they mean for our patients. We understand that adjustments in medication availability can be concerning, but we want to reassure you that we are actively working to safeguard your treatment options.
As I often remind my patients—these medications are just one tool in our toolbox. While GLP-1’s have proven to be valuable in weight management, they are not the only solutions available. We have a variety of approaches and resources to support your health and wellness journey, tailored to your unique needs.
If you have any concerns or need assistance navigating these changes, please reach out. Our team is here to help you find the best path forward and ensure your weight loss journey remains on track, no matter what adjustments come our way.
Stay informed, stay supported, and remember—you’re not in this alone. We’re with you every step of the way.